GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
ADRB2, AKR1B1, AR, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GPER1, HSD17B2, IGF1R, MAOB, MMP2, MMP9, PPARA, PRKCB, PRKCD, PRKCE, RORC, SRC, TYR |
11.1923 |
[BP] GO:0010033 |
response to organic substance
|
ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MAOB, MMP2, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR |
11.1923 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
10.5098 |
[BP] GO:0042221 |
response to chemical
|
ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MAOB, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TOP1, TYR |
10.5098 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GPER1, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
9.95557 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GPER1, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
9.95557 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, MAOB, PRKCE, RORC, SRC, TYR |
9.75184 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
9.57583 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F10, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, KDR, MAOB, MET, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
9.38957 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F10, FABP4, FLT3, GPER1, KDR, MET, MMP12, MMP2, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, XDH |
8.20233 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AR, BCL2, CA2, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, GPER1, MAOB, PRKCE, PRKCG, RORC, SRC, TYR |
7.93494 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
7.93494 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
7.81138 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTPN1, SRC, XDH |
7.81138 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AXL, BCL2, CYP1B1, F10, FLT3, GPER1, KDR, MET, PDE5A, PRKCA, PRKCB, PRKCE, PTPN1, SRC, XDH |
7.78122 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX5, AR, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, FABP4, GPER1, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCD, PRKCG, RORC, SRC, TOP1, TYR |
7.76089 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AXL, BCL2, CSNK2A1, CYP1B1, F10, FLT3, GPER1, KDR, MET, MMP12, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
7.76089 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F10, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
7.76089 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PRKCD, PRKCG, PTPN1, SRC, XDH |
7.75328 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, PRKCA, PRKCE |
7.31937 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRB2, AR, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, F10, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
7.21152 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
7.16136 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
7.13244 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, HCAR2, IGF1R, KDR, MMP9, PIM1, PRKCA, PRKCD, PRKCG, PTPN1, SRC, XDH |
7.07815 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MAOB, MMP12, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR |
7.07815 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR, XDH |
7.01818 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRB2, AKR1B1, AR, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, MAOB, MMP2, PPARA, PRKCD, PRKCE, SRC |
6.98184 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AR, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, MAOB, PPARA, PRKCD, PRKCE, SRC |
6.85625 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, RORC, SRC |
6.85625 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.79363 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
6.69249 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PDE5A, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, XDH |
6.65201 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PDE5A, PIM1, PRKCA, SRC, XDH |
6.47 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2, PRKCE |
6.39257 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTPN1, SRC |
6.39103 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ADRB2, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
6.26646 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ADRB2, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
6.26646 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
6.26102 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PRKCD, PRKCG, PTPN1, SRC |
6.15188 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, GPER1, HCAR2, PPARA, PRKCD, PRKCE, RORC, SRC |
6.10817 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
6.04308 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, PRKCD, SRC |
5.99671 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
5.93911 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRB2, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTPN1, SRC |
5.93911 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.93386 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
5.89522 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, PPARA, SRC, TYR |
5.84027 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
5.83127 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRB2, AKR1B1, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PRKCB, PRKCD, PRKCE, RORC, SRC |
5.815 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.76134 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADRB2, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP1, MMP2, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR, XDH |
5.76111 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, KDR, MAOB, PRKCD, PRKCE, SRC |
5.71572 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRB2, AKR1B1, AR, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, PRKCB, PRKCD, PRKCE, RORC, SRC |
5.70685 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.70685 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.65752 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, ADRB2, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, GPER1, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PIM1, PRKCA, PRKCB, PRKCE, SRC |
5.61784 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.60644 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.59196 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PRKCA, PRKCD, PRKCG, PTPN1, SRC |
5.52346 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, KDR, MAOB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.52346 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRB2, AR, BCL2, CDC25B, ESRRB, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
5.488 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ADRB2, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
5.45298 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AR, AXL, BCL2, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC |
5.4371 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
ADRB2, AKR1B1, AR, AXL, CYP1B1, ESR1, GPER1, IGF1R, MMP2, MMP9, PRKCB, PRKCD, PRKCE, RORC, SRC |
5.41195 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ADRB2, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
5.406 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.40269 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADRB2, AKR1B1, CNR1, CNR2, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, SRC, TYR |
5.37476 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA, PRKCD, PRKCE |
5.34865 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRB2, AR, BCL2, CNR1, CNR2, CYP19A1, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PPARA, PRKCB, PRKCD, PTPN1, SRC, XDH |
5.17464 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, FABP4, FLT3, GPER1, IGF1R, MET, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
5.11117 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRB2, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
5.10231 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, HSD17B3, MET, PPARA |
5.08603 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, ADRB2, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, FLT3, GPER1, MET, PRKCB, PRKCE, SRC |
5.06023 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRB2, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, GPER1, HCAR2, MAOB, MMP12, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
5.00974 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, ESR1, ESRRA, GPER1, HCAR2, MMP12, MMP2, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
5.00974 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRB2, AR, BCL2, CDC25B, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
5.00974 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADRB2, AKR1B1, CNR1, CNR2, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, SRC, TYR |
4.99623 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRB2, AR, FLT3, GPER1, IGF1R, KDR, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
4.88131 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, HSD17B2, HSD17B3, KDR, MAOB, MET, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCD, RORC, SRC, TYR |
4.88131 |
[BP] GO:0030168 |
platelet activation
|
AXL, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.82859 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRB2, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
4.80334 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, GPER1, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
4.79198 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRB2, AR, FLT3, GPER1, KDR, PDE5A, PRKCA, PRKCE, PTPN1, SRC, XDH |
4.77545 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, XDH |
4.75859 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRB2, AR, BCL2, CNR2, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTPN1, SRC, XDH |
4.75354 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, ESR1, FABP4, FLT3, GPER1, IGF1R, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
4.75209 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F10, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
4.75209 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRB2, AR, BCL2, CNR2, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTPN1, SRC, XDH |
4.74912 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
4.68603 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.67581 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, GPER1, IGF1R, MET, MMP12, MMP2, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, SRC, XDH |
4.66134 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CSNK2A1, ESR1, FLT3, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA |
4.65433 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
4.63771 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.6135 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
4.5688 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, GPER1, KDR, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCG |
4.50117 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRB2, BCL2, CNR1, CSNK2A1, ESRRB, HCAR2, KDR, MET, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
4.49308 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, GPER1, MMP12, MMP2, PPARA, PRKCD, PRKCE, PTPN1, SRC |
4.48137 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
4.3862 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, ADRB2, CNR1, PPARA |
4.37274 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRB2, AR, BCL2, CDC25B, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
4.35608 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HSD17B3, PDE5A, PIM1, PPARA, TYR, XDH |
4.3216 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
4.26675 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADRB2, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR, XDH |
4.26451 |
[BP] GO:0043393 |
regulation of protein binding
|
ADRB2, AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC |
4.26451 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PPARA, PRKCG, RORC, SRC, TOP1 |
4.26179 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CNR1, GPER1, HCAR2, KDR, PRKCE, SRC |
4.25541 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, FLT3, GPER1, MET, MMP9, PDE5A, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
4.23412 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, GPER1, KDR, PRKCE, SRC |
4.23262 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADRB2, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR, XDH |
4.20358 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MET, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1, XDH |
4.08947 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRB2, CA2, CA7, CNR1, CNR2, GPER1, PRKCE |
4.07546 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRB2, CA2, CA7, CNR1, CNR2, GPER1, PRKCE |
4.07546 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, ADRB2, AKR1B1, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, ESR1, F10, FLT3, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1, TYR, XDH |
4.04948 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, PRKCE, SRC |
3.96002 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ADRB2, AR, AURKB, AXL, BCL2, CNR1, ESR1, GPER1, IGF1R, KDR, MET, MMP1, MMP9, PRKCD, PRKCE, SRC |
3.93786 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SRC, XDH |
3.9202 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.91048 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.89687 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.89687 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, HSD17B3, MAOB, TYR, XDH |
3.89613 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.83557 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.83557 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MET, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1, XDH |
3.81379 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PRKCB, PRKCD, PRKCE, PTPN1, RORC, SRC |
3.81189 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, PRKCD, SRC, TYR |
3.80482 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRB2, AR, BCL2, CDC25B, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.80246 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, ADRB2, MMP1, MMP12, MMP2, MMP9 |
3.77256 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, GPER1, MMP12, PPARA, PRKCD |
3.73553 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, PRKCD, SRC |
3.73553 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, PRKCD, SRC |
3.73553 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.69895 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
3.69895 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.67967 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.63254 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, SRC |
3.61408 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
3.60829 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD |
3.60518 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, GPER1, PPARA, PRKCD |
3.60381 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.58487 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRB2, AR, BCL2, CDC25B, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, SRC, XDH |
3.5836 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.53554 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, SRC |
3.53554 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
3.50814 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1, SRC |
3.50806 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, SRC |
3.50806 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRB2, AR, BCL2, CDC25B, CSNK2A1, ESR1, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.50806 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.50732 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.50717 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRB2, CA2, CA7, GPER1, PRKCE |
3.50717 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, PPARA, PRKCE, RORC, SRC |
3.50717 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.50717 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, PPARA, PRKCE, SRC |
3.49849 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PRKCD, PRKCE, SRC |
3.4736 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, MAOB, MMP9, PIM1, PPARA, RORC, SRC, TYR |
3.4402 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.43738 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, ADRB2, AKR1B1, AURKB, BCL2, CA2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, SRC, TYR |
3.42641 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, F10, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.38608 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRB2, BCL2, CA2, CA7, CNR1, GPER1, MAOB, MMP9, PRKCD, PRKCE |
3.36944 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.36943 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, GPER1, PPARA, PRKCD |
3.31889 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
3.30925 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, SRC |
3.30925 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.30882 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRB2, AR, BCL2, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTPN1, SRC, XDH |
3.30409 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AR, AURKB, BCL2, CNR1, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, MET, MMP12, MMP9, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
3.2717 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, XDH |
3.2702 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, ADRB2, AKR1B1, AXL, BCL2, CYP1B1, GPER1, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
3.25366 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.25343 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRB2, AR, BCL2, CDC25B, ESR1, FLT3, GPER1, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.24857 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD |
3.24857 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.24857 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, GPER1, IGF1R, MET, MMP9, PRKCD, PTPN1, SRC, XDH |
3.20392 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADRB1, ADRB2, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, MET, MMP12, PPARA, PRKCD, PRKCG, PTPN1, RORC, SRC |
3.20392 |
[BP] GO:0007190 |
None
|
ADORA3, ADRB1, ADRB2, PRKCA |
3.20202 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, MAOB, MMP9, PRKCE |
3.18584 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
3.16271 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, BCL2, CA2, FLT3, GPER1, MAOB, SRC |
3.1594 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOB, TYR |
3.14069 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD |
3.09244 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CNR1, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
3.06916 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, ADRB2, AR, CNR1, PPARA |
3.06916 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.06191 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
3.06191 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, GPER1, MET, PRKCB, PRKCE |
3.06088 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRB2, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, GPER1, KDR, PDE5A, PIM1, PRKCA, PRKCB, SRC |
3.02985 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
3.0187 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.0187 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CNR1, GPER1, HCAR2, MMP12, PRKCA, PRKCD, PRKCE, PTPN1, SRC |
3.01307 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, GPER1, HCAR2, MAOB, MMP12, PRKCA, PRKCE, SRC |
2.98602 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRB2, AXL, BCL2, CA2, CYP19A1, GPER1, HCAR2, MMP12, PRKCD, PRKCE, SRC |
2.98602 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.98602 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRB2, AKR1B1, AR, ESR1, FLT3, GPER1, IGF1R, MMP2, PRKCD, PRKCE, SRC |
2.98296 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.98187 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, ADRB2, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, KDR, MET, MMP12, PPARA, PRKCD, RORC, SRC |
2.96392 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
2.89808 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CNR1, GPER1, HCAR2, MMP12, PRKCA, PRKCE, SRC |
2.88559 |
[BP] GO:0051098 |
regulation of binding
|
ADRB2, AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC |
2.88512 |
[BP] GO:0032091 |
negative regulation of protein binding
|
ADRB2, AURKB, MET, PPARA, PRKCD |
2.83931 |
[BP] GO:1901652 |
response to peptide
|
ADRB2, AKR1B1, FABP3, GPER1, IGF1R, PPARA, PRKCD, SRC |
2.83603 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, RORC, SRC |
2.82136 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, ADRB2, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, GPER1, KDR, PDE5A, PIM1, PPARA, PRKCA, PRKCB, RORC, SRC, XDH |
2.82136 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.81926 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, GPER1, HCAR2, MMP12, PRKCE, SRC |
2.79743 |
[BP] GO:0050866 |
negative regulation of cell activation
|
AXL, CNR1, CNR2, GPER1, PDE5A, PRKCD |
2.79636 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.78868 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, GPER1, PRKCE, RORC, SRC |
2.78584 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB |
2.77012 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.74916 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GPER1, PPARA, PRKCE, RORC, SRC |
2.74916 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, SRC |
2.73636 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, GPER1, HCAR2, MAOB, MMP12, PRKCA, PRKCE, SRC |
2.73355 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, AR, BCL2, CNR1, CSNK2A1, GPER1, HCAR2, MMP12, PRKCA, PRKCD, PRKCE, PTPN1, SRC |
2.73132 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, HCAR2, MET, PPARA, PRKCG |
2.73092 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, GPER1, HCAR2, PRKCA, PRKCE |
2.73092 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AR, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSD17B3, MMP2, MMP9, SRC |
2.72623 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, MAOB, PRKCE, SRC |
2.70475 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.66425 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR, XDH |
2.65173 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
2.65169 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, ADRB2, CNR1, CNR2, GPER1 |
2.64492 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ADRB2, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, ESR1, ESR2, GPER1, IGF1R, KDR, MET, MMP1, MMP9, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
2.62751 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AXL, BCL2, CA2, CNR2, CYP1A1, CYP1A2, CYP1B1, GPER1, MMP2, MMP9, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
2.62531 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.62531 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.62531 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62531 |
[BP] GO:0002025 |
None
|
ADRB1, ADRB2 |
2.62531 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, SRC |
2.61486 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, GPER1, HCAR2, MMP12, PRKCE, SRC |
2.61142 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD, PRKCE, SRC |
2.5684 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, ADRB2, AXL, BCL2, CA1, CSNK2A1, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.5456 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, ADRB2, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, MET, MMP12, PPARA, PRKCD, RORC, SRC |
2.53796 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, PRKCD, SRC |
2.52714 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, ADRB2, AURKB, BCL2, CDC25B, ESR1, FLT3, GPER1, PDE5A, PRKCD, PRKCE, PTPN1, SRC, XDH |
2.52522 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, ADRB2, AKR1B1, MET |
2.51647 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
ADRB2, BCL2, CNR1, ESRRB, KDR, MET, PPARA, PRKCA, PRKCD, PRKCG, PTPN1 |
2.51647 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.51125 |
[BP] GO:0042391 |
None
|
ADORA1, ADRB2, BCL2, CNR1, CNR2, GPER1, KDR, SRC |
2.48894 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, F10, MET, PRKCA, PRKCD, PRKCE, XDH |
2.48894 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.47616 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.46151 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.46151 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.46151 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, SRC |
2.45966 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CNR1, CNR2, CYP19A1, GPER1, MMP12, PDE5A |
2.45191 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, FLT3, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC |
2.41121 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.40745 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
2.40317 |
[BP] GO:1901653 |
cellular response to peptide
|
ADRB2, AKR1B1, GPER1, IGF1R, PRKCD, SRC |
2.38583 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.38139 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
2.37749 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA |
2.37635 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRB2, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, XDH |
2.37635 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.37635 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.37635 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.37635 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, GPER1, MET, SRC, XDH |
2.3677 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, CNR1, GPER1, HCAR2, MMP12, PRKCA, PRKCD, PRKCE, PTPN1, SRC |
2.35718 |
[BP] GO:0050708 |
None
|
ACHE, CNR1, GPER1, HCAR2, MMP12, PRKCA, PRKCE, SRC |
2.34573 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, SRC |
2.32788 |
[BP] GO:0045932 |
None
|
ADORA1, ADRB2, PDE5A |
2.32171 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRB2, AR, BCL2, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PDE5A, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, SRC, XDH |
2.30664 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.30368 |
[BP] GO:0050865 |
regulation of cell activation
|
AXL, BCL2, CNR1, CNR2, GPER1, PDE5A, PRKCA, PRKCD, SRC |
2.30128 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9 |
2.29051 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ADRB2, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, ESR1, F10, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1 |
2.28294 |
[BP] GO:0051172 |
None
|
AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, MMP12, MMP9, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
2.27339 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PRKCE, SRC |
2.27026 |
[BP] GO:2000241 |
regulation of reproductive process
|
AR, CNR1, ESR1, PDE5A, SRC |
2.25544 |
[BP] GO:0002684 |
positive regulation of immune system process
|
AXL, BCL2, CA2, CNR1, HCAR2, MMP12, MMP2, PRKCA, PRKCB, PRKCD, PRKCE, SRC |
2.2483 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.24671 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, XDH |
2.23891 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, GPER1, HCAR2 |
2.23157 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.22832 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRB2, CSNK2A1, ESRRB, KDR, PPARA, PRKCD, PRKCE, PTPN1 |
2.22659 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.20897 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.20162 |
[BP] GO:0050873 |
None
|
ADRB1, ADRB2, FABP4 |
2.20162 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.20162 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.19632 |
[BP] GO:0050730 |
None
|
ADORA1, FLT3, PRKCD, PRKCE, PTPN1, SRC |
2.19174 |
[BP] GO:1900542 |
None
|
ADRB1, ESRRB, GPER1, PDE5A, PPARA, PRKCA |
2.1625 |
[BP] GO:0051385 |
None
|
GPER1, MAOB, SRC |
2.1625 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, XDH |
2.16134 |
[BP] GO:0050714 |
None
|
ACHE, GPER1, HCAR2, MMP12, PRKCE, SRC |
2.15695 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, IGF1R, PDE5A, PRKCD, PTPN1, SRC |
2.15425 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, MAOB, TYR |
2.13688 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
2.13537 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, ESR1, FLT3, GPER1, PRKCD, PRKCE, SRC |
2.13537 |
[BP] GO:0046627 |
None
|
PRKCB, PRKCD, PTPN1 |
2.12848 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, MAOB |
2.12848 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.12128 |
[BP] GO:0006140 |
None
|
ADRB1, ESRRB, GPER1, PDE5A, PPARA, PRKCA |
2.1078 |
[BP] GO:0002695 |
negative regulation of leukocyte activation
|
AXL, CNR1, CNR2, GPER1, PDE5A |
2.10779 |
[BP] GO:1903076 |
None
|
AR, CSNK2A1, GPER1, PRKCE |
2.10473 |
[BP] GO:0045833 |
None
|
ADORA1, CNR1, GPER1, HCAR2 |
2.10473 |
[BP] GO:0001659 |
None
|
ADORA1, ADRB1, ADRB2 |
2.09344 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, PRKCE, SRC |
2.08909 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.08909 |
[BP] GO:1905475 |
None
|
AR, BCL2, CSNK2A1, GPER1, PRKCE |
2.08909 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, GPER1, HCAR2, MMP9, PRKCD, SRC, XDH |
2.07118 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, PRKCD |
2.07118 |
[BP] GO:0051100 |
negative regulation of binding
|
ADRB2, AURKB, MET, PPARA, PRKCD |
2.06951 |
[BP] GO:0031960 |
response to corticosteroid
|
BCL2, FLT3, GPER1, MAOB, SRC |
2.06951 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, ADRB2, GPER1, SRC |
2.06951 |
[BP] GO:0043278 |
None
|
CNR1, PRKCE, PRKCG |
2.06848 |
[BP] GO:0014072 |
None
|
CNR1, PRKCE, PRKCG |
2.06848 |
[BP] GO:2000273 |
None
|
ADORA1, ADRB2, PRKCE |
2.06848 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, GPER1, HCAR2, MMP12, PRKCE, SRC |
2.06848 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, ADRB2, CNR1, GPER1 |
2.06848 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.06848 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.06848 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.06848 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, GPER1, HCAR2, MMP9, PRKCD, SRC, XDH |
2.0583 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ADRB2, AURKB, BCL2, GPER1, KDR, MET, MMP9, PRKCE, SRC |
2.04881 |
[BP] GO:1900077 |
None
|
PRKCB, PRKCD, PTPN1 |
2.03928 |
[BP] GO:0010907 |
None
|
ESRRB, PPARA, SRC |
2.03928 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ADRB2, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, ESR1, F10, FLT3, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1 |
2.02196 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.01768 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, AR, AXL, CA12, CA14, CA2, CA4, CNR1, CNR2, CSNK2A1, ESR1, F10, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
3.24857 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CYP19A1, FLT3, GPER1, HSD17B3, KDR, PRKCA, PRKCD, PRKCE, PTPN1, XDH |
3.06916 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, F10, FABP3, FABP4, FLT3, GPER1, HSD17B1, HSD17B2, HSD17B3, KDR, MAOB, MMP2, MMP9, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1, TYR, XDH |
2.98602 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, CA4, GPER1, PRKCA, PRKCD, PRKCE, PRKCG, SRC, TYR |
2.50734 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRB1, ADRB2, AKR1B1, AKR1B10, AOX1, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HSD17B3, IGF1R, KDR, MAOB, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SHBG, SRC, TOP1, TYR, XDH |
2.35557 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ADRB2, ALOX5, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F10, FLT3, GPER1, HCAR2, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TYR |
2.2626 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.06848 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TYR, XDH |
15.158 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, TYR, XDH |
8.97467 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC |
8.97068 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.29232 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.29232 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.20233 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, RORC, SHBG |
7.95275 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.80793 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1, TYR, XDH |
7.59743 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, TYR, XDH |
6.26646 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
6.22722 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
6.07015 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, TYR, XDH |
5.93911 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
5.65752 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.49655 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.20879 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.20879 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, GPER1, HSD17B1, PPARA, RORC, SHBG |
5.15172 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA, PRKCE, RORC |
4.92747 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
4.91786 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, HSD17B3, MAOB, TYR, XDH |
4.80996 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
4.79198 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AR, AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
4.74912 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.6135 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.53882 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, HSD17B3, XDH |
4.30304 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.26451 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, IGF1R, SHBG |
4.26088 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
4.00423 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.89687 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.89687 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRB1, ADRB2, AOX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSD17B1, IGF1R, KDR, MAOB, MET, MMP12, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SHBG, SRC, TOP1, XDH |
3.86659 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, XDH |
3.81379 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
3.73553 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.7192 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.6468 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.60381 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, F10, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP1 |
3.50717 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRB2, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
3.49849 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
3.25343 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.2233 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, FLT3, HSD17B1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, XDH |
3.18584 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, FLT3, HSD17B1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, XDH |
3.18584 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
3.15766 |
[MF] GO:0043168 |
anion binding
|
AOX1, AURKB, AXL, CSNK2A1, F10, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, XDH |
3.12276 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRB2, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
3.09244 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.0187 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
3.0187 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.95278 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.91516 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.89808 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CSNK2A1, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TOP1 |
2.88142 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.74916 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, MAOB, SRC, XDH |
2.69636 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.63318 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.62531 |
[MF] GO:0004939 |
None
|
ADRB1, ADRB2 |
2.62531 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.62531 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, HSD17B3 |
2.50474 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, ADRB2, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, ESR1, ESR2, ESRRB, MET, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.50057 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.37749 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
2.37749 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.37635 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.37635 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
2.2857 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
2.25972 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.25544 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.23891 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MAOB, MET, MMP12, PDE5A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TOP1, XDH |
2.21742 |
[MF] GO:0051380 |
None
|
ADRB1, ADRB2 |
2.19632 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD17B1, HSD17B2, HSD17B3 |
2.1625 |
[MF] GO:0008134 |
transcription factor binding
|
AR, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, PRKCB, SRC |
2.14987 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.09344 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.06951 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.06848 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.06848 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
HSD17B2, HSD17B3 |
2.06848 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AXL, CNR1, CNR2, FLT3, GPER1, HCAR2, IGF1R, KDR, MET |
2.03422 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, ADRB2, AXL, CNR1, CNR2, FLT3, GPER1, HCAR2, IGF1R, KDR, MET |
2.03422 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRB2, AOX1, BCL2, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KDR, MAOB, MET, MMP9, TYR, XDH |
2.00425 |